Publications by authors named "Poonam Pegu"

Claim this Profile
L
Late boosting of the RV144 regimen with AIDSVAX B/E and ALVAC-HIV in HIV-uninfected Thai volunteers: a double-blind, randomised controlled trial.
Punnee Pitisuttithum, Sorachai Nitayaphan, Suwat Chariyalertsak, Jaranit Kaewkungwal, Peter Dawson, Poonam Pegu

Lancet HIV· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
First-in-Human Randomized, Controlled Trial of Mosaic HIV-1 Immunogens Delivered via a Modified Vaccinia Ankara Vector.
Lindsey R Baden, Stephen R Walsh, Michael S Seaman, Yehuda Z Cohen, Jennifer A Johnson, Poonam Pegu

J Infect Dis· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and Immunogenicity of PENNVAX-G DNA Prime Administered by Biojector 2000 or CELLECTRA Electroporation Device With Modified Vaccinia Ankara-CMDR Boost.
Julie A Ake, Alexandra Schuetz, Poonam Pegu, Lindsay Wieczorek, Michael A Eller

J Infect Dis· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized, Double-Blind Evaluation of Late Boost Strategies for HIV-Uninfected Vaccine Recipients in the RV144 HIV Vaccine Efficacy Trial.
Supachai Rerks-Ngarm, Punnee Pitisuttithum, Jean-Louis Excler, Sorachai Nitayaphan, Jaranit Kaewkungwal, Poonam Pegu

J Infect Dis· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Boosting of ALVAC-SIV Vaccine-Primed Macaques with the CD4-SIVgp120 Fusion Protein Elicits Antibodies to V2 Associated with a Decreased Risk of SIVmac251 Acquisition.
Shari N Gordon, Namal P M Liyanage, Melvin N Doster, Monica Vaccari, Diego A Vargas-Inchaustegui, Poonam Pegu

J Immunol· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Corrigendum: Adjuvant-dependent innate and adaptive immune signatures of risk of SIVmac251 acquisition.
Monica Vaccari, Shari N Gordon, Slim Fourati, Luca Schifanella, Namal P M Liyanage, Poonam Pegu

Nat Med· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adjuvant-dependent innate and adaptive immune signatures of risk of SIVmac251 acquisition.
Monica Vaccari, Shari N Gordon, Slim Fourati, Luca Schifanella, Namal P M Liyanage, Poonam Pegu

Nat Med· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Glucocorticoid treatment at moderate doses of SIVmac251-infected rhesus macaques decreases the frequency of circulating CD14+CD16++ monocytes but does not alter the tissue virus reservoir.
Marcin Moniuszko, Namal P M Liyanage, Melvin N Doster, Robyn Washington Parks, Kamil Grubczak, Poonam Pegu

AIDS Res Hum Retroviruses· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enhanced in vitro transcytosis of simian immunodeficiency virus mediated by vaccine-induced antibody predicts transmitted/founder strain number after rectal challenge.
Sandeep Gupta, Poonam Pegu, David J Venzon, Johannes S Gach, Zhong-Min Ma

J Infect Dis· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antibody to the gp120 V1/V2 loops and CD4+ and CD8+ T cell responses in protection from SIVmac251 vaginal acquisition and persistent viremia.
Shari N Gordon, Melvin N Doster, Rhonda C Kines, Brandon F Keele, Egidio Brocca-Cofano, Poonam Pegu

J Immunol· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative analysis of SIV-specific cellular immune responses induced by different vaccine platforms in rhesus macaques.
Antonio Valentin, Katherine McKinnon, Jinyao Li, Margherita Rosati, Viraj Kulkarni, Poonam Pegu

Clin Immunol· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Humoral immunity induced by mucosal and/or systemic SIV-specific vaccine platforms suggests novel combinatorial approaches for enhancing responses.
Diego A Vargas-Inchaustegui, Iskra Tuero, Venkatramanan Mohanram, Thomas Musich, Poonam Pegu

Clin Immunol· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antiretroviral therapy partly reverses the systemic and mucosal distribution of NK cell subsets that is altered by SIVmac₂₅₁ infection of macaques.
Namal P M Liyanage, Shari N Gordon, Melvin N Doster, Poonam Pegu, Monica Vaccari

Virology· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antibodies with high avidity to the gp120 envelope protein in protection from simian immunodeficiency virus SIV(mac251) acquisition in an immunization regimen that mimics the RV-144 Thai trial.
Poonam Pegu, Monica Vaccari, Shari Gordon, Brandon F Keele, Melvin Doster

J Virol· February 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TRIM5α does not affect simian immunodeficiency virus SIV(mac251) replication in vaccinated or unvaccinated Indian rhesus macaques following intrarectal challenge exposure.
Claudio Fenizia, Brandon F Keele, David Nichols, Stefano Cornara, Nicolò Binello, Poonam Pegu

J Virol· December 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Induction of strong anti-HIV cellular immunity by a combination of Clostridium perfringens expressing HIV gag and virus like particles.
Poonam Pegu, Ruth Helmus, Phalguni Gupta, Patrick Tarwater, Lori Caruso

Curr HIV Res· December 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis